Jilin Aodong Medicine

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Jilin Aodong Medicine:
Typical Co-investors
Jilin Aodong Medicine is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Jilin Aodong Medicine:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arpwood Capital India, Maharashtra, Mumbai
Boo Commercial JSC -
Capital Fun -
EastBridge Partners Seoul, Seoul-t'ukpyolsi, South Korea
EGS Healthcare Capital Partners Connecticut, Norwalk, United States
Greater Victoria Angel Network British Columbia, Canada, Victoria
Groupe du Louvre France, Ile-de-France, Paris
Guanfu Touzi China, Hangzhou, Zhejiang
Guotai Asset Management China, Hongkou District
Happy Farm Business Accelerator -
INPG Entreprise France, Grenoble, Rhone-Alpes
Navigator Technology Ventures Cambridge, Massachusetts, United States
Paul Run Holding China, Guangdong, Shenzhen
Pomegranate Investment AB -
Principle Capital China, Shanghai
Rangos Investments -
Red Apple Group New York, New York, United States
Sienna Ventures California, San Rafael, United States
VLane Capital Beijing, Beijing, China
Yusan Capital China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biopharma
Biotechnology
Health Care
$46M01 Jan 2019 Guangdong Province

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Jilin Aodong Medicine?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: